Proinsulin C-Peptide Inhibits Lipolysis in Diabetic Rat Adipose Tissue Through Phosphodiestrase-3B Enzyme

Abstract

We have previously reported that C-peptide modulates insulin-mediated inhibition of lipolysis and glucose consumption but has no significant effects per se on adipose tissue of normal rats. It has been repeatedly observed that certain actions of C-peptide are restricted to the diabetic states. In the present study, therefore, we examined whether C-peptide alters lipolysis in adipose tissue of diabetic rats. Rats were rendered diabetic by streptozotocin and divided into 2 groups; insulin treated and untreated. Retroperitoneal adipose tissue was excised aseptically, subjected to organ culture and incubated with rat C-peptide, insulin, or a combination of both peptides in the presence or absence of isoproterenol. Tissue lipolysis was assessed by the rate of glycerol release into the culture media. The cultures were pretreated with cilostamide, a phosphodiesterase-3B enzyme inhibitor, when the role of this enzyme was to be examined. C-Peptide on its own, like insulin, significantly inhibited isoproterenol-stimulated lipolysis in the adipose tissue of untreated diabetic rats. The effect was enhanced by a combination of C-peptide and insulin. Notably, the C-peptide’s effect was totally blocked in the presence of cilostamide. In the adipose tissue of insulin treated rats, however, C-peptide failed to show any significant antilipolytic effects. These data show that C-peptide has the potential to act, conditionally, as an antilipolytic hormone by activating phosphodiesterase-3B and suggest that the action may contribute to the C-peptide’s beneficial effects on diabetes-induced complications.

Key words

C-peptide - type 1 diabetes - adipose tissue

• References

• 1 Marques RG, Fontaine MJ, Rogers J. C-peptide: Much more than a byproduct of insulin biosynthesis. Pancreas. 2004. 29. 231-238
• 2 Wahren J. C-Peptide: new findings and therapeutic implications in diabetes. Clin Physiol Funct Imaging 2004; 24: 180-189
• 3 Li L, Oshida Y, Kusunoki M, Yamanouchi K, Johansson BL, Wahren J, Sato Y. Rat C peptide I and II stimulate glucose utilization in STZ-induced diabetic rats. Diabetologia 1999; 42: 958-964
• 4 Arner P. Human fat cell lipolysis: biochemistry, regulation and clinical role. Best Pract Res Clin Endocrinol Metab 2005; 19: 471-482
• 5 Carmen GY, Victor SM. Signalling mechanisms regulating lipolysis. Cell Signal 2006; 18: 401-408
• 6 Foster DW, Esser V. Ketoacidosis and Hyperosmolar Coma. In: DeGroot L, Jameson JL. (eds.). Endocrinology. Philadelphia: Elsevier; 2006: 1185-1195
• 7 Ryden M, Arner P. Fat loss in cachexia – is there a role for adipocyte lipolysis?. Clin Nutr 2007; 26: 1-6
• 8 Johansson BL, Kernell S, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993; 77: 976-981
• 9 Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson OT, Nygren P, Stahl S, Ekberg K, Johansson B, Uhlen S, Uhlen M, Jornvall H, Wahren J. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999; 96: 13318-13323
• 10 Grunberger G, Qiang X, Li Z, Mathews ST, Sbrissa D, Shisheva A, Sima AA. Molecular basis for the insulinomimetic effects of C-peptide. Diabetologia 2001; 44: 1247-1257
• 11 Ghorbani A, Omrani GR, Hadjzadeh MA, Varedi M. Effects of rat C-peptide-II on lipolysis and glucose consumption in cultured rat adipose tissue. Exp Clin Endocrinol Diabetes 2011; 119: 343-347
• 12 Ghorbani A, Varedi M, Hadjzadeh MA, Omrani GH. Type-1 diabetes induces depot-specific alterations in adipocyte diameter and mass of adipose tissues in the rat. Exp Clin Endocrinol Diabetes 2010; 118: 442-448
• 13 Ghorbani A, Varedi M, Omrani GR. Effects of aging associated weight gain on the cell size and heterogeneity of different fat depots in the rat. Iranian J Endocrinol Metab 2009; 11: 713-720
• 14 Sima AA, Zhang W, Sugimoto K, Henry D, Li Z, Wahren J, Grunberger G. C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 2001; 44: 889-897
• 15 Sima AAF, Srinivas PR, Kommaraju S, Vema S, Wahren J, Grunberg G. Enhancement of insulin receptor activity by C-peptide (Abstract). Diabetologia 1998; 41 (Suppl. 01) A177
• 16 Grunberger G, Sima AA. The C-peptide signaling. Exp Diabesity Res 2004; 5: 25-36
• 17 Varedi M, Tredget EE, Ghahary A, Scott PG. Stress-relaxation and contraction of a collagen matrix induces expression of TGF-b and triggers apoptosis in dermal fibroblasts. Biochem Cell Biol 2000; 78: 427-436
• 18 Solomon SS, Brush JS, Kitabchi AE. Anti-lipolysis activity of insulin and proinsulin on ACTH and cyclic nucleotide-induced lipolysis in the isolated adipose cell of rat. Biochim Biophys Acta 1970; 218: 167-169
• 19 Nordquist L, Moe E, Sjoquist M. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 2007; 23: 400-405
• 20 Al-Rasheed NM, Willars GB, Brunskill NJ. C-peptide signals via Galpha i to protect against TNF-alpha-mediated apoptosis of opossum kidney proximal tubular cells. J Am Soci Nephrol 2006; 17: 986-995
• 21 Zinder O, Shapiro B. Effect of cell size on epinephrine- and ACTH-induced fatty acid release from isolated fat cells. J Lipid Res 1971; 12: 91-95
• 22 Berger JJ, Barnard RJ. Effect of diet on fat cell size and hormone-sensitive lipase activity. J Appl Physiol 1999; 87: 227-232
• 23 Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lonn M. Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006; 20: 1540-1542
• 24 Ahmad F, Lindh R, Tang Y, Weston M, Degerman E, Manganiello VC. Insulin-induced formation of macromolecular complexes involved in activation of cyclic nucleotide phosphodiestrase 3B (PDE3B) and its interaction with PKB. Biochem J 2007; 404: 257-268
• 25 Choi YH, Park S, Hockman S, Zmuda-Trzebiatowska E, Svennelid F, Haluzik M, Gavrilova O, Ahmad F, Pepin L, Napolitano M, Taira M, Sundler F, Stenson Holst L, Degerman E, Manganiello VC. Alterations in regulation of energy homoeostasis in cyclic nucleotide phosphodiestrase 3B-null mice. J Clin Invest 2006; 116: 3240-3251
• 26 Snyder PB, Esselstyn JM, Loughney K, Wolda SL, Florio VA. The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J Lipid Res 2005; 46: 494-503
• 27 Alinejad B, Shafiee-Nick R, Ghorbani A. The effect of cilostamide derivatives on lipolysis of rat retroperitoneal adipose tissue (Abstract). Clin Biochem 2011; 44: S248
• 28 Francis SH, Blount MA, Corbin JD. Mammalian cyclic nucleotide phosphodiestrases: molecular mechanisms and physiological functions. Physiol Rev 2011; 91: 651-690
• 29 Nerelius C, Alvelius G, Jornvall H. N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation. Biochem Biophys Res Commun 2010; 403: 462-467
• 30 Jornvall H, Lindahl E, Astorga-Wells J, Lind J, Holmlund A, Melles E, Alvelius G, Nerelius C, Maler L, Johansson J. Oligomerization and insulin interactions of proinsulin C-peptide: Threefold relationships to properties of insulin. Biochem Biophys Res Commun 2010; 391: 1561-1566
• 31 Re RN, Cook JL. Noncanonical intracrine action. J Am Soc Hypertens 2012; 5: 435-448
• 32 Lindahl E, Nordquist L, Muller P, Agha EE, Friederich M, Dahlman-Wright K, Palm F, Jornvall H. Diabetes Metab Res Rev 2011; 27: 697-704